Literature DB >> 33732777

Polyamine Transport Assay Using Reconstituted Yeast Membranes.

Sarah Van Veen1, Shaun Martin1, Marleen Schuermans1, Peter Vangheluwe1.   

Abstract

ATP13A2/PARK9 is a late endo-/lysosomal P5B transport ATPase that is associated with several neurodegenerative disorders. We recently characterized ATP13A2 as a lysosomal polyamine exporter, which sheds light on the molecular identity of the unknown mammalian polyamine transport system. Here, we describe step by step a protocol to measure radiolabeled polyamine transport in reconstituted vesicles from yeast cells overexpressing human ATP13A2. This protocol was developed as part of our recent publication (van Veen et al., 2020 ) and will be useful for characterizing the transport function of other putative polyamine transporters, such as isoforms of the P5B transport ATPases.
Copyright © 2021 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  ATP13A2; P5 ATPase; Polyamine; Reconstitution; Spermine; Transport assay; Yeast membranes

Year:  2021        PMID: 33732777      PMCID: PMC7952932          DOI: 10.21769/BioProtoc.3888

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  14 in total

1.  Polyamine transport systems in mammalian cells and tissues.

Authors:  Takeshi Uemura; Eugene W Gerner
Journal:  Methods Mol Biol       Date:  2011

2.  Evolution of substrate specificities in the P-type ATPase superfamily.

Authors:  K B Axelsen; M G Palmgren
Journal:  J Mol Evol       Date:  1998-01       Impact factor: 2.395

3.  Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase.

Authors:  Alfredo Ramirez; André Heimbach; Jan Gründemann; Barbara Stiller; Dan Hampshire; L Pablo Cid; Ingrid Goebel; Ammar F Mubaidin; Abdul-Latif Wriekat; Jochen Roeper; Amir Al-Din; Axel M Hillmer; Meliha Karsak; Birgit Liss; C Geoffrey Woods; Maria I Behrens; Christian Kubisch
Journal:  Nat Genet       Date:  2006-09-10       Impact factor: 38.330

4.  A lipid switch unlocks Parkinson's disease-associated ATP13A2.

Authors:  Tine Holemans; Danny Mollerup Sørensen; Sarah van Veen; Shaun Martin; Diane Hermans; Gerdi Christine Kemmer; Chris Van den Haute; Veerle Baekelandt; Thomas Günther Pomorski; Patrizia Agostinis; Frank Wuytack; Michael Palmgren; Jan Eggermont; Peter Vangheluwe
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-01       Impact factor: 11.205

5.  Expression in yeast and purification of a membrane protein, SERCA1a, using a biotinylated acceptor domain.

Authors:  Marie Jidenko; Guillaume Lenoir; José M Fuentes; Marc le Maire; Christine Jaxel
Journal:  Protein Expr Purif       Date:  2006-03-24       Impact factor: 1.650

6.  Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism.

Authors:  Jin-Sung Park; Prachi Mehta; Antony A Cooper; David Veivers; André Heimbach; Barbara Stiller; Christian Kubisch; Victor S Fung; Dimitri Krainc; Alan Mackay-Sim; Carolyn M Sue
Journal:  Hum Mutat       Date:  2011-07-12       Impact factor: 4.878

7.  Measuring Ca2+-dependent Ca2+-uptake activity in the mouse heart.

Authors:  Tine Holemans; Ilse Vandecaetsbeek; Frank Wuytack; Peter Vangheluwe
Journal:  Cold Spring Harb Protoc       Date:  2014-08-01

8.  Transformation of yeast by lithium acetate/single-stranded carrier DNA/polyethylene glycol method.

Authors:  R Daniel Gietz; Robin A Woods
Journal:  Methods Enzymol       Date:  2002       Impact factor: 1.600

9.  Flippase activity detected with unlabeled lipids by shape changes of giant unilamellar vesicles.

Authors:  Andreas Papadopulos; Stefanie Vehring; Iván López-Montero; Lara Kutschenko; Martin Stöckl; Philippe F Devaux; Michael Kozlov; Thomas Pomorski; Andreas Herrmann
Journal:  J Biol Chem       Date:  2007-03-17       Impact factor: 5.157

10.  ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease.

Authors:  A Di Fonzo; H F Chien; M Socal; S Giraudo; C Tassorelli; G Iliceto; G Fabbrini; R Marconi; E Fincati; G Abbruzzese; P Marini; F Squitieri; M W Horstink; P Montagna; A Dalla Libera; F Stocchi; S Goldwurm; J J Ferreira; G Meco; E Martignoni; L Lopiano; L B Jardim; B A Oostra; E R Barbosa; V Bonifati
Journal:  Neurology       Date:  2007-05-08       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.